| (19) |
 |
|
(11) |
EP 1 900 741 A8 |
| (12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
Note: Bibliography reflects the latest situation |
| (15) |
Correction information: |
|
Corrected version no 1 (W1 A1) |
| (48) |
Corrigendum issued on: |
|
04.08.2010 Bulletin 2010/31 |
| (43) |
Date of publication: |
|
19.03.2008 Bulletin 2008/12 |
| (22) |
Date of filing: 01.10.2001 |
|
| (51) |
International Patent Classification (IPC):
|
|
| (84) |
Designated Contracting States: |
|
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
Designated Extension States: |
|
SI |
| (30) |
Priority: |
02.10.2000 PH 270100
13.10.2000 WO PCT/SE00/01994
|
| (62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
01972866.6 / 1330462 |
| (71) |
Applicant: AstraZeneca AB |
|
151 85 Södertälje (SE) |
|
| (72) |
Inventor: |
|
- Pavey, John
Loughborough, Leicestershire LE11 5RH (GB)
|
|
| |
|
|
|
Remarks: |
|
This application was filed on 29-11-2007 as a divisional application to the application
mentioned under INID code 62. |
|
| (54) |
New process for the production of oxabispidines |
(57) There is provided a process for the preparation of a compound of formula I, (I),
or a pharmaceutically acceptable derivative thereof, wherein A, B, G, R
1, R
2, R
3, R
4 and R
41 to R
46 have meanings given in the description, which process comprises the dehydrative cyclisaton
of a compound of formula II, (II).